Bvf Inc Eiger Bio Pharmaceuticals, Inc. Transaction History

Bvf Inc

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$5.4 - $13.37 $367,491 - $909,881	-68,054 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$4.91 - $14.7 $370,768 - $1.11 Million	-75,513 Reduced 52.6%	68,054 $463,000
Q4 2019 Feb 14, 2020	SELL	$9.77 - $15.66 $3.87 Million - $6.2 Million	-395,945 Reduced 73.39%	143,567 $2.14 Million
Q3 2019 Nov 14, 2019	SELL	$9.59 - $12.0 $1.3 Million - $1.63 Million	-135,488 Reduced 20.07%	539,512 $5.53 Million
Q4 2018 Feb 14, 2019	BUY	$8.63 - $12.4 $5.83 Million - $8.37 Million	675,000 New	675,000 $6.86 Million

748K

Ticker EIGR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,966,800
Market Cap $496M
Description
Eiger BioPharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of targeted therapies for rare and ultra-rare diseases in the United States and internationally. Its lead product candidate is Lonafarnib, an orally bioavailable, small molecule, which is in Phase III clinical trials to ...

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

Stay updated on Bvf Inc with notifications on news.